Hisamitsu Pharmaceutical Co., Inc.
Executive Personnel Changes
For the Annual General Meeting of Shareholders to be held in May 2026, 10 director candidates have been nominated. One new director and one resigning director have been decided.
Key Figures
- Number of Director Candidates: 10 (1 Representative Director, 9 Directors)
- New Director: Sakae Yano (currently Senior Executive Officer)
- Resigning Director: Yuichiro Anzai (currently Outside Director)
AI要約
Regarding the Nomination of Director Candidates
Hisamitsu Pharmaceutical Co., Inc. has decided to nominate all 10 current directors as director candidates at the Annual General Meeting of Shareholders scheduled for May 28, 2026, due to the expiration of their terms. The composition includes one representative director and nine directors. Additionally, Mr. Sakae Yano (currently Senior Executive Officer) will be newly nominated as a director candidate. The representative director will be selected at the Board of Directors meeting following the conclusion of the Annual General Meeting.
Regarding Resigning Director
Mr. Yuichiro Anzai, the current outside director, is scheduled to resign. As a result, the director changes consist of one new appointment and one resignation. This executive personnel change aims to strengthen the organizational structure while maintaining management continuity.
